299 related articles for article (PubMed ID: 28231038)
1. Medication-Related Osteonecrosis of the Jaw and Dental Implants Failures: A Systematic Review.
Guazzo R; Sbricoli L; Ricci S; Bressan E; Piattelli A; Iaculli F
J Oral Implantol; 2017 Feb; 43(1):51-57. PubMed ID: 28231038
[TBL] [Abstract][Full Text] [Related]
2. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
Madrid C; Sanz M
Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact on Dental Implant Survival in Patients Taking Antiresorptive Medications: A Systematic Review and Meta-Analysis.
Ting M; Huynh BH; Woldu HG; Gamal I; Suzuki JB
J Oral Implantol; 2023 Dec; 49(6):599-615. PubMed ID: 37905745
[TBL] [Abstract][Full Text] [Related]
5. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
Schmitt CM; Buchbender M; Lutz R; Neukam FW
Eur J Oral Implantol; 2018; 11 Suppl 1():S93-S111. PubMed ID: 30109302
[TBL] [Abstract][Full Text] [Related]
6. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report.
Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T
J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295
[TBL] [Abstract][Full Text] [Related]
7. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
8. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
9. No increased risk of osteonecrosis of the jaw in osteoporotic patients with dental implants: a nationwide cohort study.
Park JH; Lee JR; Lee H; Lee HJ; Kim JW
Clin Oral Investig; 2024 Jan; 28(1):83. PubMed ID: 38195947
[TBL] [Abstract][Full Text] [Related]
10. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
11. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
12. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
Famili P; Quigley S; Mosher T
Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
[TBL] [Abstract][Full Text] [Related]
13. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review.
Javed F; Almas K
J Periodontol; 2010 Apr; 81(4):479-84. PubMed ID: 20367090
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic risk of osteonecrosis of the jaw? Bone substitutes for dental implants: a warning from Japan.
Hibi H
Nagoya J Med Sci; 2020 Feb; 82(1):1-3. PubMed ID: 32273626
[TBL] [Abstract][Full Text] [Related]
15. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
[TBL] [Abstract][Full Text] [Related]
16. Antiresorptive drug-related osteonecrosis of the jaw.
Uyanne J; Calhoun CC; Le AD
Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
[TBL] [Abstract][Full Text] [Related]
17. Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy.
Mozzati M; Arata V; Giacomello M; Del Fabbro M; Gallesio G; Mortellaro C; Bergamasco L
J Craniofac Surg; 2015 May; 26(3):749-55. PubMed ID: 25974785
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: A literature review.
Kuroshima S; Sasaki M; Sawase T
J Oral Biosci; 2019 Jun; 61(2):99-104. PubMed ID: 31109863
[TBL] [Abstract][Full Text] [Related]
19. Is implant surgery a risk factor for osteonecrosis of the jaw in older adult patients with osteoporosis? A national cohort propensity score-matched study.
Ryu JI; Kim HY; Kwon YD
Clin Oral Implants Res; 2021 Apr; 32(4):437-447. PubMed ID: 33452837
[TBL] [Abstract][Full Text] [Related]
20. Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review.
Papadakis I; Spanou A; Kalyvas D
J Oral Implantol; 2021 Apr; 47(2):169-180. PubMed ID: 32663267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
